|
|
|
Volumn 46, Issue 3, 2012, Pages 434-451
|
|
[DNA vaccine encoding alpha-fetoprotein with fused ornithine decarboxylase degradation signal significantly suppresses hepatocellular carcinoma growth in mice].
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA FETOPROTEIN;
CANCER VACCINE;
DNA VACCINE;
HYBRID PROTEIN;
ORNITHINE DECARBOXYLASE;
PROTEASOME;
REVERSE TRANSCRIPTASE, HUMAN IMMUNODEFICIENCY VIRUS 1;
RNA DIRECTED DNA POLYMERASE;
SIGNAL PEPTIDE;
TUMOR MARKER;
ADAPTIVE IMMUNITY;
ANIMAL;
ARTICLE;
C57BL MOUSE;
CELL STRAIN HEK293;
DRUG EFFECT;
GENETIC TRANSFECTION;
GENETICS;
HUMAN;
IMMUNIZATION;
IMMUNOLOGY;
LIVER CELL CARCINOMA;
LIVER TUMOR;
METABOLISM;
MOUSE;
PLASMID;
TUMOR VOLUME;
ADAPTIVE IMMUNITY;
ALPHA-FETOPROTEINS;
ANIMALS;
CANCER VACCINES;
CARCINOMA, HEPATOCELLULAR;
HEK293 CELLS;
HIV REVERSE TRANSCRIPTASE;
HUMANS;
IMMUNIZATION;
LIVER NEOPLASMS, EXPERIMENTAL;
MICE;
MICE, INBRED C57BL;
ORNITHINE DECARBOXYLASE;
PLASMIDS;
PROTEASOME ENDOPEPTIDASE COMPLEX;
PROTEIN SORTING SIGNALS;
RECOMBINANT FUSION PROTEINS;
TRANSFECTION;
TUMOR BURDEN;
TUMOR MARKERS, BIOLOGICAL;
VACCINES, DNA;
|
|
EID: 84865414055
PISSN: 00268984
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
